Across TCGA pan-cancer cohorts, KRT8P30 RNA is linked to patient survival in 26 of 34 cancer types, making it the most broadly survival-associated KRT8P30 data layer.
The strongest signal is observed in brain lower grade glioma (LGG), where higher KRT8P30 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated KRT8P30 expression acts as an unfavorable survival marker, although some lineages such as LGG and CESC show a favorable association.
LGG, COAD, and KIRC are the cancer types where KRT8P30 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.